Your SlideShare is downloading. ×
Researchmoz Provide Medi point  total hip replacement - us analysis and market forecasts Report
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Researchmoz Provide Medi point total hip replacement - us analysis and market forecasts Report

108
views

Published on

Osteoarthritis has become a global public health concern with no cure. It is the most common form of arthritis that is primarily due to wear and tear of the joints. With the aging global population, …

Osteoarthritis has become a global public health concern with no cure. It is the most common form of arthritis that is primarily due to wear and tear of the joints. With the aging global population, this is an indication that is growing rapidly with the hip being one of the most common joints afflicted. While the primary indication for total hip replacement (THR) is osteoporosis, the other major indications for THR are osteonecrosis and fractures to a lesser degree. As people live longer and with younger patients also receiving implants, the revision rates for primary hip replacements are also expected to rise. Primary hip replacement has become one of the most successful surgeries, with a variety of femoral and acetabular components available from a wide selection of manufacturers. This report focuses on the total primary hip replacement market along with primary revision market. The global hip replacement market has been estimated in this report which includes the US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India. The report provides unmet needs, future adoption and compounded annual growth rates (CAGR).

GlobalDatas analysis shows that the hip replacement market has become a mature market where products have become commodities. The future of the market lays on the ability of manufacturers to provide implants at a very low cost while continuing to provide the same level of clinical efficacy. The product development need lies primarily in revising the resurfacing products articulating surface with new materials rather than developing new acetabular and femoral components. Additionally the major opportunity lies within the emerging markets which are the countries that have a higher CAGR and will provide the key for growth and grabbing market share.

View Detail Report With TOC At : http://www.researchmoz.us/medipoint-total-hip-replacement-us-analysis-and-market-forecasts-report.html

Published in: Health & Medicine, Business

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
108
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. MediPoint: Total Hip Replacement - US Analysis and Market Forecasts Osteoarthritis has become a global public health concern with no cure. It is the most common form of arthritis that is primarily due to wear and tear of the joints. With the aging global population, this is an indication that is growing rapidly with the hip being one of the most common joints afflicted. While the primary indication for total hip replacement (THR) is osteoporosis, the other major indications for THR are osteonecrosis and fractures to a lesser degree. As people live longer and with younger patients also receiving implants, the revision rates for primary hip replacements are also expected to rise. Primary hip replacement has become one of the most successful surgeries, with a variety of femoral and acetabular components available from a wide selection of manufacturers. This report focuses on the total primary hip replacement market along with primary revision market. The global hip replacement market has been estimated in this report which includes the US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India. The report provides unmet needs, future adoption and compounded annual growth rates (CAGR). GlobalDatas analysis shows that the hip replacement market has become a mature market where products have become commodities. The future of the market lays on the ability of manufacturers to provide implants at a very low cost while continuing to provide the same level of clinical efficacy. The product development need lies primarily in revising the resurfacing products articulating surface with new materials rather than developing new acetabular and femoral components. Additionally the major opportunity lies within the emerging markets which are the countries that have a higher CAGR and will provide the key for growth and grabbing market share. The mature market in the design of hip replacement products has led to a shift in the focus of developing orthopedic implants. Orthopedic surgery in the hip has become more minimally invasive unlike that of the past, with smaller incision sizes, the development of computer-navigated arthroplasty systems and even bone-preserving techniques such as resurfacing. This report addresses the various unmet needs, presents the current technology and the drivers for the future and market growth in the US. Adoption rates are examined, as well as the decision-makers, in order capture market share. Scope An overview of arthritis, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. Annualized US THR market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018. Investigation of current and future market competition for THR Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. Competitor assessment including device approval analysis and device sales forecasts. Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. Analysis of unmet needs within the market and opportunities for future players. Technology trends evaluation to assess strength of pipeline. An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. Company profiles including business description, financial overview and SWOT analysis. Coverage of key market players. Strategic assessment of the THR sector through market impact analysis, future market scenario and company analysis. Direct quotes from Key Opinion Leaders (KOL) as well as Orthopedic Surgeon MediPoint: Total Hip Replacement - US Analysis and Market Forecasts
  • 2. Reasons to buy Understand the trends shaping and driving the US THR Market. Realize device preferences of physicians who have performed the tests already. Access market sizing, forecasts and quantified growth opportunities in the US THR market through 2018. Quantify candidate patient populations to better design product pricing & launch plans. Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. Perform benchmarking analysis of growth opportunities against currently marketed products. Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. Take a comprehensive look at the markets device pipeline and identify promising, paradigm-shifting products. Create an effective counter-strategy to gain a competitive advantage against those currently in the market. Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth. Whats the next big thing in US THR market landscape? Identify, understand and capitalize. table Of Contents 1 Table Of Contents 1 Table Of Contents 7 1.1 List Of Tables 16 1.2 List Of Figures 26 2 Introduction 30 2.1 Catalyst 31 3 Disease Overview 33 3.1 Anatomy And Physiology 33 3.2 Pathophysiology 34 3.2.1 Overview 34 3.2.2 Osteoarthritis 34 3.2.3 Rheumatoid Arthritis 35 3.2.4 Post-traumatic Arthritis 36 3.2.5 Osteonecrosis 36 3.2.6 Injury 36 3.2.7 Bone Tumors 37 3.2.8 Other Diseases 37 3.3 Clinical Presentation 38 3.4 Clinical Outcomes 39 3.4.1 Overview 39 3.4.2 Conservative Therapy 41 3.4.3 Hip Arthroscopy 41 3.4.4 Hip Arthrodesis 42 MediPoint: Total Hip Replacement - US Analysis and Market Forecasts
  • 3. 3.4.5 Hemiarthroplasty (partial) 43 3.4.6 Core Decompression 43 3.4.7 Hip Osteotomy 44 3.4.8 Resection Arthroplasty 44 3.4.9 Primary Total Hip Replacement 45 3.4.10 Revision Total Hip Replacement 47 3.4.11 Resurfacing Arthroplasty 48 3.4.12 Computer-navigated Hip Replacement 49 3.5 Surgical Approaches 49 3.5.1 Anterolateral Approach 51 3.5.2 Posterior Approach 51 3.5.3 Direct Anterior Approach 52 3.5.4 Minimally Invasive Approaches 52 3.6 Epidemiology 53 3.6.1 Us 54 3.7 Economic Impact 55 3.7.1 Us 56 4 Competitive Assessment 58 4.1 Overview Of Historical Designs 58 4.2 Marketed Products 59 4.2.1 Global Market Share 59 4.2.2 Primary Total Hip Replacement 61 4.2.3 Product Profiles By Company 61 5 Unmet Needs 203 5.1 Long-term Clinical Data 203 5.2 Need For Continued Materials Research 203 5.3 Bearings 205 5.4 Refocus Of Pipeline Products 206 5.5 Renewal Of Resurfacing 207 5.6 Addressing The Learning Curve For Tier Ii Surgeons 208 5.7 Need For Cost Containment 210 5.8 Centralization 211 5.9 National Joint Registry 211 6 Pipeline Products 213 6.1 Overview 213 6.2 Primary Total Hip Pipeline Products 213 6.2.1 Exactech Lpi Prime Hip System 213 MediPoint: Total Hip Replacement - US Analysis and Market Forecasts
  • 4. 6.2.2 Enduro Bone-preserving Hip Stem 214 6.2.3 Deltamotion Acetabular Cup System 214 6.2.4 Novosource Hip Implant 215 7 Industry Overview 216 7.1 Procedure Volumes 216 7.1.1 Us 217 7.2 Market Access 218 7.2.1 Us 218 7.3 Reimbursement Trends 221 7.3.1 Us 221 7.4 Regulatory Issues/recalls 223 7.4.1 Depuy Hip Replacement Recall 224 7.4.2 Stryker Hip Replacement Recall 224 7.4.3 Smith & Nephew Recall: R3 Metal Liners Of The R3 Acetabular System 224 7.4.4 Zimmer Durom® Acetabular Component 225 7.4.5 Biomet Hip Replacement Complications 225 7.4.6 Wright Medical Conserve Hip Implant 225 7.4.7 The Corin Group Metal-on-metal Hip Resurfacing 225 7.5 Mergers & Acquisitions / Key Partnerships 226 7.5.1 Medtronic Acquires China Kanghui Holdings 226 7.5.2 Tornier Acquires Orthohelix Surgical Designs Inc. 226 7.5.3 Depuy Orthopaedics (johnson & Johnson) And Synthes Inc. Merge 227 7.5.4 Italian Consortium 2il Orthopaedics Ltd Acquires Corin Group 227 7.5.5 Zimmer Acquires Beijing Montagne Medical Device Co. Ltd. 227 7.5.6 Wright Medial Announces Agreement To Sell Orthorecon Business To Microport Medical B.v. 228 8 Company Profiles 229 8.1 B. Braun 229 8.1.1 Overview 229 8.1.2 Portfolio Assessment 230 8.1.3 Swot Analysis 230 8.2 Biomet Orthopedics 231 8.2.1 Overview 231 8.2.2 Portfolio Assessment 232 8.2.3 Swot Analysis 235 8.3 Corentec Co. Ltd. 236 8.3.1 Overview 236 8.3.2 Portfolio Assessment 236 8.3.3 Swot Analysis 237 8.4 Corin 237 MediPoint: Total Hip Replacement - US Analysis and Market Forecasts
  • 5. 8.4.1 Overview 237 8.4.2 Portfolio Assessment 238 8.4.3 Swot Analysis 239 8.5 Depuy Synthes International 240 8.5.1 Overview 240 8.5.2 Portfolio Assessment 241 8.5.3 Swot Analysis 244 8.6 Exactech 244 8.6.1 Overview 244 8.6.2 Portfolio Assessment 245 8.6.3 Swot Analysis 247 8.7 Iconacy Orthopedic Implants Llc 247 8.7.1 Overview 247 8.7.2 Portfolio Assessment 248 8.7.3 Swot Analysis 248 8.8 Implantcast Gmbh 249 8.8.1 Overview 249 8.8.2 Portfolio Assessment 249 8.8.3 Swot Analysis 251 8.9 Jri Orthopaedics 251 8.9.1 Overview 251 8.9.2 Portfolio Assessment 252 8.9.3 Swot Analysis 253 8.10 Kyocera 253 8.10.1 Overview 253 8.10.2 Portfolio Assessment 254 8.10.3 Swot Analysis 255 8.11 Limacorporate S.p.a 255 8.11.1 Overview 255 8.11.2 Portfolio Assessment 256 8.11.3 Swot Analysis 257 8.12 Medacta 258 8.12.1 Overview 258 8.12.2 Portfolio Assessment 258 8.12.3 Swot Analysis 259 8.13 Medtronic 260 8.13.1 Overview 260 8.13.2 Portfolio Assessment 261 8.13.3 Swot Analysis 262 8.14 Novosource Inc. 262 8.14.1 Overview 262 8.14.2 Portfolio Assessment 263 8.14.3 Swot Analysis 264 MediPoint: Total Hip Replacement - US Analysis and Market Forecasts
  • 6. 8.15 Peter Brehm Gmbh 264 8.15.1 Overview 264 8.15.2 Portfolio Assessment 265 8.15.3 Swot Analysis 265 8.16 Serf Dedienne Santé 266 8.16.1 Overview 266 8.16.2 Portfolio Assessment 267 8.16.3 Swot Analysis 268 8.17 Smith & Nephew 268 8.17.1 Overview 268 8.17.2 Portfolio Assessment 269 8.17.3 Swot Analysis 271 8.18 Stelkast 271 8.18.1 Overview 271 8.18.2 Portfolio Assessment 272 8.18.3 Swot Analysis 272 8.19 Stryker 273 8.19.1 Overview 273 8.19.2 Portfolio Assessment 274 8.19.3 Swot Analysis 275 8.20 Tianjin Zhengtian Medical Instrument Co., Ltd. 276 8.20.1 Overview 276 8.20.2 Portfolio Assessment 276 8.20.3 Swot Analysis 277 8.21 Tornier N.v. 278 8.21.1 Overview 278 8.21.2 Portfolio Assessment 279 8.21.3 Swot Analysis 281 8.22 Wright Medical 281 8.22.1 Overview 281 8.22.2 Portfolio Assessment 282 8.22.3 Swot Analysis 284 8.23 United Orthopedic Corporation 285 8.23.1 Overview 285 8.23.2 Portfolio Assessment 285 8.23.3 Swot Analysis 286 8.24 Zimmer Holdings Inc. 287 8.24.1 Overview 287 8.24.2 Portfolio Assessment 288 8.24.3 Swot Analysis 290 8.25 Other Companies 291 MediPoint: Total Hip Replacement - US Analysis and Market Forecasts
  • 7. 9 Market Drivers, Opportunities And Barriers 292 9.1 Market Drivers 292 9.1.1 Prevalence Rise 292 9.1.2 Expanding Indications 294 9.1.3 Availability And Lack Of Long-term Clinical Data 295 9.1.4 Fracture Incidence 295 9.1.5 Patient Demand And Awareness 295 9.2 Opportunities 296 9.2.1 Revision Surgery 296 9.2.2 Emerging Markets 296 9.2.3 Continued Materials Research 297 9.2.4 Corporate Promotions And Teaching Seminars 298 9.2.5 Advancement Towards Cost Reduction 298 9.3 Market Barriers 299 9.3.1 Market Barriers 299 10 Country Outlooks & Forecasts 303 10.1 Us Market Analysis 303 11 Appendix 307 11.1 Abbreviations 307 11.2 Bibliography 308 11.3 Report Methodology 325 11.3.1 Overview 325 11.3.2 Coverage 325 11.3.3 Secondary Research 326 11.3.4 Forecasting Methodology 327 11.3.5 Primary Research – Key Opinion Leader Interviews 328 11.3.6 Expert Panel Validation 328 11.4 Physicians And Specialists Included In This Study 329 11.4.1 Dr. Alessandro Aprato 329 11.4.2 Dr. Fran Channa 329 11.4.3 Joseph Daniel Frcs Ms (orth) 329 11.4.4 Dr. Alejandro Gonzalez Della Valle 329 11.4.5 Dr. Moussa Hamadouche 329 11.4.6 Dr. Sheng-li Huang And Xi-jing He 329 11.4.7 Dr. Ayumi Kaneuji 329 11.4.8 Dr. Yuichi Mitani 329 11.4.9 Dr. Ning Lu 330 11.4.10 Dr. Deepak Saini 330 11.4.11 Dr. Lafayette Lage 330 MediPoint: Total Hip Replacement - US Analysis and Market Forecasts
  • 8. 11.4.12 Dr. Christoph Zilkens 330 11.5 About The Authors 331 11.5.1 Analysts 331 11.5.2 Global Head Of Healthcare 332 11.6 About Medipoint 333 11.7 About Globaldata 333 11.8 Disclaimer 333 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ MediPoint: Total Hip Replacement - US Analysis and Market Forecasts